EN
HI
Venmax Drugs And Pharmaceuticals Chart
Venmax Drugs And Pharmaceuticals Share Key Metrics
Volume
5361.00
Market Cap
20.15 CR
LTQ@LTP
1@21.11
ATP
21.6
Var Margin
26.1 %
Circuit Range
18.36-27.52
Delivery %
95.59 %
Value
1.16 L
ASM/GSM
No
Market Lot
1
Summary
Venmax Drugs And Pharmaceuticals share price is ₹21.11 as of 2 Jun, 2026. The stock Venmax Drugs And Pharmaceuticals intraday movement has stayed between ₹19.26 and ₹24.99, while on a 52-week basis,Venmax Drugs And Pharmaceuticals price 52 week high is ₹36.96 & its 52 week low is ₹19.01.
In terms of trading activity, Venmax Drugs And Pharmaceuticals has recorded a volume of 5361 shares, The Venmax Drugs And Pharmaceuticals has a market cap of ₹8782930 CR. The stock’s Average Traded Price (ATP) stands at ₹21.60, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹21.11.
Venmax Drugs And Pharmaceuticals operates within a circuit range of ₹18.36 – ₹27.52, with a Value of ₹1.16 L. The Delivery Percentage for the day is 95.59%. Additionally, Venmax Drugs And Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Venmax Drugs And Pharmaceuticals Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.96
Sector P/B
3.02
Sec. Div. Yield
0.55
Venmax Drugs And Pharmaceuticals Resistance and Support
Pivot 22.98
Resistance
First Resistance
23.96
Second Resistance
24.98
Third Resistance
25.96
Support
First Support
21.96
Second Support
20.98
Third Support
19.96
Venmax Drugs And Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-14 | Audited Results |
| 2026-02-07 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-09-02 | Amalgamation & A.G.M. |
| 2025-08-16 | Others |
| 2025-07-23 | Quarterly Results |
| 2025-05-09 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2025-01-11 | Preferential issue of shares |
Venmax Drugs And Pharmaceuticals News
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
Venmax Drugs & Pharmaceuticals has scheduled a Board Meeting for May 14, 2026. The meeting's agenda includes considering and approving the audited financial results for the quarter and financial year ended March 31, 2026.
May 06 2026 16:57:16
Venmax Drugs And Pharmaceuticals Management
| Name | Position |
|---|---|
| Priyanka Agarwal | Company Secretary & Compliance Officer |
| Venkata Rao Sadhanala | Whole Time Director |
Venmax Drugs And Pharmaceuticals Similar Stocks
Venmax Drugs And Pharmaceuticals FAQs
The Buying Price of Venmax Drugs And Pharmaceuticals share is 21.11 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Venmax Drugs And Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Venmax Drugs And Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Venmax Drugs And Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Venmax Drugs And Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Venmax Drugs And Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.96 & 3.02 with sector averages, along with growth rates and financial metrics.
The Market Cap of Venmax Drugs And Pharmaceuticals is 20.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Venmax Drugs And Pharmaceuticals share price is 36.96 & 19.01. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Venmax Drugs And Pharmaceuticals belongs to the Healthcare sector.
